Reference
Pandya C, et al. Cost effectiveness analysis of early versus late autologous stem cell transplantation (ASCT) in multiple myeloma (MM). Clinical Transplantation : 17 Jul 2014. Available from: URL: http://doi.org/10.1111/ctr.12421
Rights and permissions
About this article
Cite this article
Early ASCT well worth it for eligible MM patients in the US. PharmacoEcon Outcomes News 709, 5 (2014). https://doi.org/10.1007/s40274-014-1452-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1452-4